Live Webinar WED at 2PM PST- Prostate Cancer
cells from prostate cancer patients with short telomeres and hypervariable lengths were 14X more likely to die of their disease
cells from prostate cancer patients with short telomeres and hypervariable lengths were 14X more likely to die of their disease
In long-awaited and landmark study published yesterday in Genetics, Lapham and 28 other authors collaborated to report telomere length in a cohort of Kaiser patients who gave saliva samples.
So in a sense, good health is like keeping a bathtub full of clean water. The supply of water is nearly endless if we can keep the mesenchymal stem cell library frozen in our cartilage from aging when recruited. And if we can drain out the foul water (mutated stem cells), then we are going to be just fine.
Men who developed cancers were compared with those that didn’t for the 13 years prior to diagnosis or exclusion by using a quantitative PCR measurement (which is problematic). Firstly, they found was two different curves with the cancer group showing a more rapid shortening trend. This is consistent with my stem cell theory of aging and most of the extant studies.
Truly, the best argument against my Stem Cell Theory of Aging (since every Axiom in it is completely standard scientific orthodoxy) is that “it couldn’t be that simple because the best efforts of scientists have been looking elsewhere.”
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness